Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience

被引:100
作者
Salo, JC
Paty, PB
Guillem, J
Minsky, BD
Harrison, LB
Cohen, AM
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[3] Beth Israel Med Ctr, Dept Radiat Oncol, New York, NY 10003 USA
关键词
rectal cancer; local recurrence; surgery; survival;
D O I
10.1007/s10434-999-0171-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Local recurrence after resection of rectal carcinoma is a difficult clinical problem that adversely affects both survival and quality of life. Surgical resection is possible for a subset of patients with localized recurrences. We reviewed our experience with surgical salvage of recurrent rectal carcinoma, to determine predictors of resectability and postsalvage survival rates. Methods: A 10-year, retrospective analysis of 131 patients who underwent exploration with curative intent for local recurrence after radical resection of rectal carcinomas, in a single referral institution, was performed. Preoperative and pathological factors were examined for their ability to predict postresection survival rates and resectability. Results: The overall 5-year survival rate for patients who underwent exploration with curative intent was 24%. Resection of recurrent disease was possible for 103 of 131 (79%) patients, with a resulting 5-year survival rate of 31%. Patients who were treated initially with abdomino-perineal resection (n = 35) presented later and were less likely to have resectable tumors than were those treated initially with some form of sphincter-preserving resection (n = 96). Among patients who could undergo resection, normal carcinoembryonic antigen levels and recurrent disease limited to the bowel wall were both favorable features. Conclusions: Surgical salvage of local recurrence after radical resection of rectal carcinoma can be performed safely and can result in substantial long-term survival benefits for selected patients.
引用
收藏
页码:171 / 177
页数:7
相关论文
共 22 条
[1]   AGGRESSIVE SURGICAL-MANAGEMENT OF LOCALLY ADVANCED PRIMARY AND RECURRENT RECTAL-CANCER - CURRENT STATUS AND FUTURE-DIRECTIONS [J].
COHEN, AM ;
MINSKY, BD .
DISEASES OF THE COLON & RECTUM, 1990, 33 (05) :432-438
[2]  
GUNDERSON LL, 1974, CANCER-AM CANCER SOC, V34, P1278, DOI 10.1002/1097-0142(197410)34:4<1278::AID-CNCR2820340440>3.0.CO
[3]  
2-F
[4]  
Harrison L B, 1995, Oncology (Williston Park), V9, P737
[5]  
HARRISON LE, 1997, J AM COLL SURGEONS, V185, P50
[6]   PTNM AND RESIDUAL TUMOR CLASSIFICATIONS PROBLEMS OF ASSESSMENT AND PROGNOSTIC-SIGNIFICANCE [J].
HERMANEK, P .
WORLD JOURNAL OF SURGERY, 1995, 19 (02) :184-190
[7]   Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer [J].
Minsky, BD ;
Cohen, AM ;
Enker, WE ;
Saltz, L ;
Guillem, JG ;
Paty, PB ;
Kelsen, DP ;
Kemeny, N ;
Ilson, D ;
Bass, J ;
Conti, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (02) :289-295
[8]  
MINSKY BD, 1996, RADIAT ONCOL INVEST, V4, P90
[9]  
PIHL E, 1981, SURG GYNECOL OBSTET, V153, P495
[10]  
PILIPSHEN SJ, 1984, CANCER-AM CANCER SOC, V53, P1354, DOI 10.1002/1097-0142(19840315)53:6<1354::AID-CNCR2820530623>3.0.CO